Avantor Inc. (AVTR) exhibits 32.7% gross margins and -2.1% return on invested capital within Health Care (Biotechnology: Laboratory Analytical Instruments), balanced against a 24.0x enterprise multiple and 4.8% implied options volatility.
Sustained 32.7% gross profitability converts into -3.8% operating margin and -2.1% ROIC, outpacing sector cost of capital.
ROIC: -2.1% // GM: 32.7%YoY revenue trajectory of -3.4% paired with 4.38% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -3.4% // FCF YLD: 4.38%Altman Z-Score of 1.88 and Piotroski F-Score of 5/9 indicate low near-term refinancing stress.
ALTMAN Z: 1.88 // F-SCORE: 5/9Trading at 24.0x trailing P/E (31.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $16.05 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Biotechnology: Laboratory Analytical Instruments require continuous execution to defend -8.1% net margins.
NET MARGIN: -8.1% // D/E: 0.70x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for AVTR & activate live FRED threshold breach alerts.